COMP <GO>
MWA vs TMO // EV/EBITDA & P/E VALUATION
MUELLER WATER PRODUCTS (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: MWA 8
— TMO 4
▲ EV/EBITDA & P/E VALUATION LEADER: MWA
LAST: $22.78 (+2.94%) • MKT CAP: $3.56B
valuation
15.4x
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
valuation
30.4x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MWA VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MWA | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 36.10% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 14.00% | 9.30% | +4.70 | MWA | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 15.4x | 30.4x | -15.00 | MWA | /valuation <GO> |
| Free Cash Flow Yield | 6.17% | 2.40% | +3.77 | MWA | /fcf-yield <GO> |
| Operating Margin | 18.20% | 17.40% | +0.80 | MWA | /operating-margins <GO> |
| Net Profit Margin | 13.40% | 15.10% | -1.70 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 8.70% | 3.90% | +4.80 | MWA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.18% | 0.24% | +0.94 | MWA | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.22 | 4.50 | -0.28 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | MWA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 59.9 | 62.9 | -2.98 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 17.3x | 36.3x | -19.00 | MWA | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.56B | $262.22B | -$258.66B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MWA REV | TMO REV | MWA GROSS % | TMO GROSS % | MWA FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.43B | $44.56B | 36.1% | — | $219.3M | $6.29B |
| FY 2024 | $1.31B | $42.88B | 34.9% | — | $238.8M | $7.27B |
| FY 2023 | $1.28B | $42.86B | — | — | $109.0M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MWA // BETA —
TMO // BETA 0.94